OLIVEIRA STEVEN MICHAEL purchased 49.7% of their position (331.88K shares) of BENITEC BIOPHARMA INC. on the open market
Open‑market purchase worth $1.50M — a major conviction buy. The strongest form of insider conviction signal.
Common Stock, par value $0,0001 per share
Shares
+100K
Price / share
$5.45
Trade value
$544.86K
% of position
Common Stock, par value $0,0001 per share
Shares
+22.88K
Price / share
$5.49
Trade value
$125.62K
% of position
Common Stock, par value $0,0001 per share
Shares
+120K
Price / share
$4.18
Trade value
$501.89K
% of position
Common Stock, par value $0,0001 per share
Shares
+40.50K
Price / share
$4.25
Trade value
$172.27K
% of position
Common Stock, par value $0,0001 per share
Shares
+37.95K
Price / share
$3.18
Trade value
$120.69K
% of position
Common Stock, par value $0,0001 per share
Shares
+10.55K
Price / share
$3.04
Trade value
$32.13K
% of position
Net shares
+331.88K
Net value
$1.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0,0001 per share Indirect | 4/28/2021 | P · Purchase | +100K | $5.45 | $544.86K | 15.0% | 668.12K | 768.12K |
| Common Stock, par value $0,0001 per share Indirect | 4/29/2021 | P · Purchase | +22.88K | $5.49 | $125.62K | 3.0% | 768.12K | 791K |
| Common Stock, par value $0,0001 per share Indirect | 4/30/2021 | P · Purchase | +120K | $4.18 | $501.89K | 15.2% | 791K | 911K |
| Common Stock, par value $0,0001 per share Indirect | 5/3/2021 | P · Purchase | +40.50K | $4.25 | $172.27K | 4.4% | 911K | 951.50K |
| Common Stock, par value $0,0001 per share Indirect | 11/29/2021 | P · Purchase | +37.95K | $3.18 | $120.69K | 4.0% | 951.50K | 989.45K |
| Common Stock, par value $0,0001 per share Indirect | 12/9/2021 | P · Purchase | +10.55K | $3.04 | $32.13K | 1.1% | 989.45K | 1M |
| Total | +331.88K | $1.50M | ||||||